Duality Advisers’s Idexx Laboratories IDXX Stock Holding History

Duality Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-682	Closed	-$379K	–	667
2023 Q4	$379K	Sell	682 -3,853	-85%	-$1.81M	0.04%	470
2023 Q3	$1.98M	Buy	+4,535	New	+$2.26M	0.24%	159
2023 Q1	–	Sell	-2,884	Closed	-$1.18M	–	654
2022 Q4	$1.18M	Buy	+2,884	New	+$1.12M	0.13%	280
2022 Q3	–	Sell	-12,317	Closed	-$4.32M	–	634
2022 Q2	$4.32M	Buy	+12,317	New	+$5.02M	0.43%	45
2021 Q4	–	Sell	-4,878	Closed	-$3.03M	–	588
2021 Q3	$3.03M	Buy	+4,878	New	+$3.28M	0.23%	173
2021 Q2	–	Sell	-12,216	Closed	-$5.98M	–	626
2021 Q1	$5.98M	Buy	+12,216	New	+$6.12M	0.52%	31
2020 Q1	–	Sell	-44,422	Closed	-$11.6M	–	159
2019 Q4	$11.6M	Buy	+44,422	New	+$11.7M	0.69%	29
2019 Q1	–	Sell	-2,330	Closed	-$433K	–	242
2018 Q4	$433K	Buy	+2,330	New	+$478K	0.03%	194

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Duality Advisers's IDXX Position: Q1 2024 in Review

Duality Advisers sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 682 shares — an estimated $379K sold.

Duality Advisers first reported a position in IDXX in Q4 2018 and held it in 8 quarters. The position peaked at $11.6M in Q4 2019. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Duality Advisers reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
Duality Advisers sold 682 Idexx Laboratories shares in Q1 2024, an estimated $379K.
Duality Advisers first reported a position in Idexx Laboratories in Q4 2018 and held it in 8 quarters.
Duality Advisers's Idexx Laboratories position peaked at $11.6M in Q4 2019.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Duality Advisers's 13F filing for Q1 2024, filed 6 May 2024.